References
- Miyai K, Ichihara K, Kondo K, et al. Asymptomatic hyperprolactinaemia and prolactinoma in the general population: mass screening by paired assays of serum prolactin. Clin Endocrinol (Oxf) 1986; 25(5): 549–54
- Franks S, Murray MA, Jequier AM, et al. Incidence and significance of hyperprolactinaemia in women with amenorrhea. Clin Endocrinol (Oxf) 1975; 4(6): 597–607
- Koppelman MC, Jaffe MJ, Rieth KG, et al. Hyperprolactinemia, amenorrhea, and galactorrhea: a retrospective assessment of twenty-five cases. Ann Intern Med 1984; 100(1): 115–21
- Sisam DA, Sheehan JP, Sheeler LR. The natural history of untreated microprolactinomas. Fertil Steril 1987; 48(1): 67–71
- Dalkin AC, Marshall JC. Medical therapy of hyperprolactinemia. Endocrinol Metab Clin North Am 1989; 18(2): 259–76
- Lamberts SW, Quik RF. A comparison of the efficacy and safety of pergolide and bromocriptine in the treatment of hyperprolactinemia. J Clin Endocrinol Metab 1991; 72(3): 635–41
- Webster J, Piscitelli G, Polli A, et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med 1994; 331(14): 904–9
- Randall RV, Laws ER Jr, Abboud CF, et al. Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas: results in 100 patients. Mayo Clin Proc 1983; 58(2): 108–21
- Serri O, Rasio E, Beauregard H, et al. Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. N Engl J Med 1983; 309(5): 280–3